Form D · Other Technology
Colorado Therapeutics LLC
Broomfield, CO · CIK 0001672459
Offering snapshot reported Apr 17, 2017 · SEC filing
- Reported sold
- $2.57M Offering amount: $15M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Apr 3, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 17, 2017 | Initial | $2,570,367 | No comparison | 5 | SEC filing |
| Apr 18, 2016 | Initial | $4,298,064 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-284943
Source: Form D, filed Apr 17, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Gleason | Director |
| James Gleeson | Director |
| Joseph Horn | Director, Executive |
| William Jackson | Executive |
| Thomas Raegan | Director |
| Thomas Reagan | Director |
| Eric Schabule | Executive |
| Eric Schauble | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2150 West 6 Th Avenue Unit L
Broomfield, CO, 80020
Broomfield, CO, 80020